Introduction

Knowledge of historical deal information is a crucial prerequisite for deal negotiations. PharmaDeal Financials are unique searchable thematic licensing databases. The databases feature deals over a 16 year period from a variety of companies, ranging from small company licensors to leading licensees like Pfizer, Novartis and GlaxoSmithKline. PharmaDeal Financial databases, which distinguish themselves by focusing on specific disease areas, indications and/or compound classes, only contain deals on therapeutics with at least one financial component. Each deal entry is categorized and searchable by licensor, licensee, indication, compound details, compound name, development stage (research – filed for regulatory approval), geographical territory, potential deal size, upfront, milestone payments, royalties on sales, research funding, equity and by year of deal establishment or any combination thereof. Next to a total of 8 standard PharmaDeal Financials databases for specific disease areas, product development phase and/or compound classes, a customized search service on deal financials according to specifications set by clients is offered under the section databases.

Unique databases

• Available to download directly on your desktop
• Focused on thematic deals only
• Fully searchable
• Quick access to financial deal specifics
• All deal information on one screen; easy comparison of deal structures
• Provides deal history from 1996 until January 2012

Benchmark your next deal

• Identify how peer group deals have been structured
• View deal trends over the last 16 years
• Calculate deal sizes based on comparable deals

Making deals happen

Use of PharmaDeal Financials actually supported deal closure for clients that purchased the databases.